Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190)

Market Cap	6.71B +9.2%
Revenue (ttm)	1.18B +35.1%
Net Income	271.94M +143.7%
EPS	0.84 +147.0%
Shares Out	334.73M
PE Ratio	23.85
Forward PE	16.54
Dividend	0.25 (1.27%)
Ex-Dividend Date	May 27, 2026

Volume	353,644
Open	20.78
Previous Close	20.70
Day's Range	20.04 - 20.80
52-Week Range	18.04 - 28.00
Beta	0.28
Analysts	Strong Buy
Price Target	30.86 (+53.99%)
Earnings Date	Mar 17, 2026

About HKG:2190

Zylox-Tonbridge Medical Technology Co., Ltd., a medical device company, provides neuro- and peripheral-vascular interventional medical devices in the People’s Republic of China and internationally. It offers a neurovascular product portfolio that covers a suite of products for various categories, including ischemic stroke, hemorrhagic stroke, intracranial stenosis, carotid artery, and intracranial access devices. The company’s peripheral-vascular interventional product portfolio includes stents, balloons, catheters, and filters, as well as cove...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2012
• Employees: 925
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2190

Financial Performance

In 2025, HKG:2190's revenue was 1.06 billion, an increase of 35.15% compared to the previous year's 782.48 million. Earnings were 244.37 million, an increase of 143.75%.

Financial numbers in CNY